Krishna Vaddi, CEO at Prelude Therapeutics Inc (PRLD), bought 1,350,000 shares at $0.69 ($932K) on 2025-03-25, disclosed to the SEC on 2025-03-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.69 | 675,000 | $466K | 50.0% |
| 2 | $0.69 | 675,000 | $466K | 50.0% |
| Total | $0.69 avg | 1,350,000 | $932K | 100% |
| Filing → |
| PRLD | BUY | 2025-03-14 | $70K | — | Filing → |
| PRLD | BUY | 2025-01-03 | $6K | — | Filing → |
| PRLD | BUY | 2025-01-02 | $12K | — | Filing → |